We serve 3-chloropropoxymethylbenzene CAS:26420-79-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 3-chloropropoxymethylbenzene
CAS.NO: 26420-79-1
Molecular Formula: C10H13ClO
Molecular Weight: 184.66300
Synonyms:
PhCH2O(CH2)3Cl
1-chloro-3-benzyloxypropane
3-benzyloxypropylchloride
3-(benzyloxy)-1-chloropropane
1-(benzyloxy)-2-chloropropane
(3-chloropropoxymethyl)benzene
1-(BENZYLOXY)-3-CHLOROPROPANE
benzyl 3-chloropropyl ether
Physical and Chemical Properties:
Density: 1.067g / cm3
Boiling point: 250ºC at 760 mmHg
Flash point: 109.9ºC
Refractive index: 1.509
Specification:
Appearance: White powder
Purity:≥98.0%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: For organic synthesis raw materials.
Contact us for information like 3-chloropropoxymethylbenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,benzyl 3-chloropropyl ether physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3-chloropropoxymethyl)benzene Use and application,benzyl 3-chloropropyl ether technical grade,usp/ep/jp grade.
Related News: It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.1,3,5-Tri-O-Benzoyl-2-Deoxy-2-Fluoro -α-D-Arabinose manufacturer It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.6-Bromo-1,2,4-triazin-3-amine supplier Catalent’s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.4-Fluoro-2-nitrobenzoic acid vendor Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.
